The EMA grants Orphan Medicinal Product status to Verastem's (VSTM) small molecule inhibitor...

|About: Verastem (VSTM)|By:, SA News Editor

The EMA grants Orphan Medicinal Product status to Verastem's (VSTM) small molecule inhibitor VS-6063 for the treatment of mesothelioma. The designation gives the drug a leg up in terms of market exclusivity upon approval and opens the door for EMA assistance throughout clinical development. (PR)